Nannan Liu
- Hepatology top 10%
- Hepatitis C virus research 4
-
- Traditional Chinese Medicine Analysis 2
-
- Liver Disease Diagnosis and Treatment 6
-
- Metabolomics and Mass Spectrometry Studies 3
- Gut microbiota and health 3
- Ginseng Biological Effects and Applications 2
-
- Cardiovascular Function and Risk Factors 3
-
- Pharmacological Effects of Natural Compounds 2
- Journals
- Scientific Reports (1 paper)International Journal of Molecular Sciences (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Nannan Liu
47 papers receiving 654 citations
Peers
Comparison fields: 5 of 90
- Hepatology 55
- Complementary and alternative medicine 49
- Neurology 43
- Epidemiology 162
- Cancer Research 68
Countries citing papers authored by Nannan Liu
This map shows the geographic impact of Nannan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nannan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nannan Liu more than expected).
Fields of papers citing papers by Nannan Liu
This network shows the impact of papers produced by Nannan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nannan Liu. The network helps show where Nannan Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nannan Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 7 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 7 | |
| 5 | 2022 | 0 | |
| 6 | 2022 | 13 | |
| 7 | 2021 | 26 | |
| 8 | 2021 | 3 | |
| 9 | 2021 | 19 | |
| 10 | 2020 | 8 | |
| 11 | 2020 | 9 | |
| 12 | 2020 | 29 | |
| 13 | 2020 | 13 | |
| 14 | 2020 | 66 | |
| 15 | 2019 | 6 | |
| 16 | 2017 | 16 | |
| 17 | 2016 | 9 | |
| 18 | 2015 | 26 | |
| 19 | 2014 | 11 | |
| 20 | 2009 | 1 |
About Nannan Liu
Nannan Liu is a scholar working on Complementary and alternative medicine, Hepatology and Pharmacology, having authored 48 papers that have together received 656 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (6 papers), Hepatitis C virus research (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers), Cardiovascular Function and Risk Factors (3 papers), Gut microbiota and health (3 papers), Ginseng Biological Effects and Applications (2 papers), Traditional Chinese Medicine Analysis (2 papers) and Pharmacological Effects of Natural Compounds (2 papers). The work is most often cited by research in Hepatology (55 citations), Complementary and alternative medicine (49 citations) and Neurology (43 citations). Nannan Liu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Mengyin Chen, Guodong Ma, Guanhua Du, Haiguang Yang, Linglei Kong, Hu Li, Zong‐Gen Peng, Xuejun Wang, Shengqi Wang and Sen Zhang. Their work appears in journals such as Scientific Reports, International Journal of Molecular Sciences and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.